Skip to main content
Log in

Antithrombogenic Activity of Antioxidant Compounds

  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

Antithrombotic activities of enoxifol, a new antioxidant with antiaggregant activity demonstrated in vitro and in vivo, and antioxidant mexidol were compared on the rat model of arterial thrombosis induced by application of 50% ferric chloride. Acetylsalicylic acid (antiaggregant) served as the reference drug. All drugs exhibited dose-dependent antithrombotic activity. Enoxifol was more effective than mexidol, both drugs being more active than the reference drug (acetylsalicylic acid). Taking into account the pathogenesis of the thrombosis in this experimental model, we can hypothesize that the pronounced antithrombotic effect of enoxifol was due to its antiaggregant and antioxidant activities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. V. A. Anisimova, A. A. Spasov, V. A. Kosolapov, et al., Khim. Farm. Zh., 43, No. 9, 9–12 (2009).

    Google Scholar 

  2. I. P. Danilov, Med. Novosti, No. 9, 17–20 (2008).

  3. V. A. Kosolapov, A. A. Spasov, and V. A. Anisimova, Biomed. Khim., 51, No. 3, 287–294 (2005).

    PubMed  CAS  Google Scholar 

  4. V. V. Nikonov and E. I. Kinoshenko, Meditsina Neotlozhn. Sost., No. 3, 109–119 (2008).

  5. V. A. Anisimova, V. A. Kosolapov, A. A. Spasov, et al., Patent of RF No. 2391979. Dihydro 9-(3,4-dihydroxyphenyl)-9-diethylaminoethylimidazo[1,2-a]benzimidazole and pharmaceutical composition based on it, Byull. Otkryt., No. 17 (2010).

  6. V. I. Petrov, N. V. Rogova, and D. O. Mikhailova, Vestn. Vol. Gos. Med. Univer., 33, No. 1, 28–32 (2010).

    Google Scholar 

  7. A. A. Spasov, O. V. Ostrovskii, I. V. Ivakhnenko, et al., Eksp. Klin. Farmakol., 62, No. 1, 38–40 (1999).

    PubMed  CAS  Google Scholar 

  8. I. N. Tyurenkov and A. V. Voronkov, Eksp. Klin. Farmakol., 71, No. 1, 49–51 (2008).

    CAS  Google Scholar 

  9. J. M. Dogne, J. Hanson, X. de Leval, et al., J. Pharmacol. Exp. Ther., 309, No. 2, 498–505 (2004).

    Article  PubMed  CAS  Google Scholar 

  10. J. E. Freedman, Arterioscler. Thromb. Vasc. Biol., 28, No. 3, s11–s16 (2008).

    Article  PubMed  CAS  Google Scholar 

  11. I. Hagedorn, T. Vogtle, and B. Nieswandt, Hemostaseologie, 30, No. 3, 127–135 (2010).

    CAS  Google Scholar 

  12. K. D. Kurz, B. W. Main, and G. E. Sandusky, Thromb. Res., 60, No. 4, 269–280 (1990).

    Article  PubMed  CAS  Google Scholar 

  13. R. J. Westrick, M. E. Winn, and D. T. Eitzman, Arterioscler. Thromb. Vasc. Biol., 27, No. 10, 2079–2093 (2007).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. A. Spasov.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 155, No. 6, pp. 740-742, June, 2013

Rights and permissions

Reprints and permissions

About this article

Cite this article

Spasov, A.A., Kucheryavenko, A.F., Kosolapov, V.A. et al. Antithrombogenic Activity of Antioxidant Compounds. Bull Exp Biol Med 155, 775–777 (2013). https://doi.org/10.1007/s10517-013-2250-x

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-013-2250-x

Key Words

Navigation